This systematized review (s=82) examines the current evidence for best therapeutic practices during administration sessions with serotonergic psychedelics and entactogens (e.g. MDMA) as adjuncts to psychotherapy. The study finds that the effects of different therapeutic models, methods, techniques, and more complex interventions on therapeutic outcomes have not been investigated rigorously, with most available evidence being anecdotal.
Abstract of Dosing and Therapeutic Conduct in Administration Sessions in Substance-Assisted Psychotherapy
“While the potential of serotonergic psychedelics and related substances as adjuncts in substance-assisted psychotherapy (SAPT) has been investigated for the treatment of several disorders, evidence for the appropriate therapeutic conduct in administration sessions is sparse. In this article, we discuss the current evidence for best therapeutic practice during administration sessions with serotonergic psychedelics and entactogens as adjuncts to psychotherapy. We conducted a systematized review of the literature following PRISMA guidelines. PsycINFO, MEDLINE, and Cochrane Library databases were searched. Clinical trials, treatment manuals, study protocols, qualitative studies, case studies, descriptive studies, opinion papers, reviews, book chapters, and conference proceedings published until February 1, 2022 were retrieved. The final synthesis included k = 82 sources. Information about substances, dosages, number of administration sessions, issues that are common for clients, different types of experiences, music, and therapeutic conduct was summarized, compared, and critically discussed. The effects different therapeutic models, methods, techniques, and more complex interventions each have on the therapeutic outcome have not been investigated by means of rigorous research. Most of the available evidence we retrieved was anecdotal limiting any conclusive statements regarding appropriate therapeutic conduct during administration sessions. Consequently, essential components of therapeutic interventions remain largely tentative, necessitating systematic investigation.“
Authors: Sascha B. Thal, M. Wieberneit, J. M. Sharbanee, P. M. Skeffington, R. Bruno, T. Wenge, and S. J. Bright
Summary of Dosing and Therapeutic Conduct in Administration Sessions in Substance-Assisted Psychotherapy
While the potential of serotonergic psychedelics and related substances as adjuncts in substance-assisted psychotherapy has been investigated, the evidence for the appropriate therapeutic conduct in administration sessions is sparse.
People have consumed psychedelics for at least 5,700 years, and the use of these substances in the general population is increasing. There are limited data to draw firm conclusions about how to handle administration sessions of substance-assisted psychotherapy.
Find this paper
https://doi.org/10.1177/00221678231168516
Open Access | Google Scholar | Backup | 🕊
Cite this paper (APA)
Thal, S. B., Wieberneit, M., Sharbanee, J. M., Skeffington, P. M., Bruno, R., Wenge, T., & Bright, S. J. (2023). Dosing and Therapeutic Conduct in Administration Sessions in Substance-Assisted Psychotherapy: A Systematized Review. Journal of Humanistic Psychology, 00221678231168516.